Instituto do Câncer do Estado de São Paulo

São Paulo 01246-000

0 studies enrolling now · 2 studies all time

What they study most

Cervical Cancer, Endometrial Cancer

Studies at this site

• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) — Running, not enrolling
• RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer — Stopped early